"VEXAS SYNDROME", a multidisciplinary team of researchers @genome_gov have identified this new disorder:
(1/8)
➡️Monogenic adult-onset autoinflammatory disease affecting males ♂️👨👦
(2/8)
➡️Caused by a mutation in the UBA1 gene 🧬 that encodes major E1 enzyme that initiates ubiquitylation
➡️Suggests postzygotic somatic mutation may be a more frequent cause of human disease👨
➡️Patients develop inflammatory symptoms🔥and hematological abnormalities🩸👇
(4/8)
🩸HEMATOLOGICAL ABNORMALITIES
👉Macrocytic anemia
👉Thrombocytopenia
👉Thrombosis
👉MDS
👉Myeloma
➡️MDS transformation to MDS with excess blasts or AML has not been noted(N Engl J Med 2020; 383:2628-2638)
➡️Some patients with thrombosis had recurrence while on anticoags💊🔁
(5/8)
➡️CLINICAL MANIFESTATIONS (PANELS) 1/2
A: Lung involvement included pulmonary infiltrates & pleural effusions
B: Vasculitis of med. sized bronchial arteries
C: Neutrophilic alveolitis
D: Characteristic vacuoles present in myeloid precursor cells from bone marrow aspirates
(6/8)
➡️CLINICAL MANIFESTATIONS (PANELS) 2/2
Cutaneous manifestations
E: Neutrophilic dermatosis with small to med.vessel vasculitis
F: Tender plaques
G: Cartilaginous involvement included auricular chondritis
H: Nasal chondritis, sometimes associated with periorbital inflamm🔥
(7/8)
👉Hematoxylin and eosin staining was used in Panels B, C, and E, and Wright–Giemsa staining was used in Panel D
➡️MORPHOLOGY👇
🧵🧵
1/18
We at HCC are so proud of our team and participating centers. 6 abstracts of our collective work have been accepted for #ASH22. If you wish to be a part of this movement either as an individual or as a participating institution, do visit us at hemecancer.org/membership.php
2/18
#2976 Prognostic Factors and Outcomes of Adolescent and Adult Burkitt Lymphoma and Leukemia from a Low-Middle Income Country: An Experience from Hematology Cancer Consortium ash.confex.com/ash/2022/webpr…
#tweetorial 🧵
🚩AL & MM - Transcriptional patterns link common causal root with differing behaviours
(1/14)
➡️Light-chain amyloidosis (AL) and multiple myeloma (MM), are plasma cell (PC) malignancies with strikingly different clinical presentations 🥼🩺
➡️Success in🎯identifying these mechanisms has thus far been limited 👎
(2/14)
➡️Alameda et al define a “transcriptional atlas” of normal PCs, AL amyloidosis, MM, and MGUS, identifying 13 different transcriptional patterns linking distinct PC dyscrasias to subsets of normal developing PCs, with diagnostic 🔬and prognostic implications
#tweetorial 🧵
🚩Metabolism and Acute Myeloid Leukemia
(1/23)
➡️📈🔎Increased attention over the last decade on the metabolic perturbations in AML
➡️Potential therapeutic implications – with ‘druggable’ targets
(2/23)
➡️🗒️📌Summary of recent concepts
🔊IT IS ALL HAPPENING IN THE MITOCHONDRIA
👉📈🏹Increase potential of targeting the mitochondria
👉🦀Anti-cancer agents specifically targeting cancer cell mitochondria are referred to as 'mitocans'
(3/23)
➡️Metabolic adaptions of AML cells
AML is a 🦀cancer derived from the myeloid lineage of blood🩸cells, characterized by overproduction of malignant cells.
👉A provisional entity in the 2016 World Health Organization classification of acute leukemia 🩸🩸
👉Gene expression 🧬signature similar to Ph-positive ALL but lacks the BCR-ABL1 translocation @NancyArthurPhD
➡️Originally defined by gene expression 🧬profiling in 2009 by 2 groups
👉Children's Oncology Group (COG) and St. Jude Children's Research Hospital (referred to as Ph-like ALL) 👉Dutch Childhood Oncology Group (referred to as BCR-ABL1-like ALL) – DCOG/COALL
👉The differences in the approaches are outlined in the figure; more on the gene expression 🧬 signatures and diagnostic conundrums later!